Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kuros Biosciences | Switzerland | Healthcare | Biotechnology & Medical Research | 16.7% | CHF 735.68M | -64.3x | -2.64 | CHF 19.58 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HBM Healthcare Investments | Switzerland | Financial | Investment Banking & Investment Services | 7.1% | CHF 1.27B | 13.9x | 0.09 | CHF 186.40 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
HBM Healthcare Investments | Switzerland | Financial | Investment Banking & Investment Services | 4.5% | CHF 1.27B | 13.9x | 0.09 | CHF 187 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | 2.4% | CHF 2.07B | 16.5x | 0.12 | CHF 37.75 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.9% Upside | Upgrade to Pro+ | |
Eeii AG | Switzerland | Financial | Investment Holding Companies | 0% | CHF 4.74M | -10.1x | -0.27 | CHF 3.10 | 24% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alpine Select | Switzerland | -2.6% | CHF 64.45M | 22.4x | 0.12 | CHF 7.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Alpine Select AG | Switzerland | Financial | Investment Banking & Investment Services | -2.6% | CHF 64.45M | 22x | 0.12 | CHF 7.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Private Equity Holding AG | Switzerland | Financial | Investment Banking & Investment Services | -6.5% | CHF 170.27M | 25.9x | 0.1 | CHF 69 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | -6.9% | CHF 2.07B | 15.9x | 0.12 | CHF 37.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Lastminute.com | Switzerland | Technology | Software & IT Services | -7.2% | CHF 178.42M | 15.5x | 0.04 | CHF 16.70 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.2% Upside | Upgrade to Pro+ | |
Santhera Pharmaceuticals Holding | Switzerland | Healthcare | Pharmaceuticals | -12.8% | CHF 97.33M | 1.4x | 0.01 | CHF 8.04 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | Switzerland | Healthcare | Pharmaceuticals | -21.1% | CHF 983.61M | 15.3x | 0.03 | CHF 61.30 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.7% Upside | Upgrade to Pro+ |